Wellfully Ltd (WFL)

Snapshot

WFL's Principal Activity is the research and development for its Dermaportation and ETP transdermal drug delivery technologies.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
03/03/2010	$0.02	100%	$0.0286	Interim	31/03/2010
26/08/2009	$0.03	100%	$0.0429	Final	15/09/2009
16/03/2009	$0.05	100%	$0.0714	Interim	06/04/2009

Show All

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM)	$0.00
Gross DPS(TTM)	$0.00
Dividend yield
Gross yield
Payout Ratio	--
DRP	No
DRP Features	-

Directors & Management

Name	Title	Since	Bio
Mr Anthony David Wright	Non-Executive Director	Apr 2021	Mr Anthony David Wright Non-Executive Director Mr Wright is an experienced senior executive with more than 20 years of experience across leadership, commercial, legal, governance, strategy, sales and marketing roles in leading global and Australian organizations including Transpacific Industries Group Ltd (now Cleanaway Ltd) and the PGA Tour. Mr Wright is an Executive Director of LOD, a company involved in the legal services market. He leads its Law Firm, Legal Operations, Legal Technology, and Risk and Compliance divisions. Prior to this, he founded and was Chief Executive Officer of Lexvoco, an award-winning legal services and tech business commenced in 2014 and operated in Australia, NZ and Japan. Lexvoco included law firm, labour hire, management consulting, risk and compliance, and tech development divisions. Lexvoco was acquired by LOD in 2019. He held multiple senior executive roles at Transpacific Industries including Group General Counsel and General Manager, Strategy and Systems, and he was a Director for the PGA Tour, commercialising and promoting professional golf tournaments in Asia Pacific, after earlier legal and accountancy-related positions.
Mr Paul Peros	Chief Executive Officer	Apr 2020
Mr Cameron Reynolds	Non-Executive Director	Jul 2018	Mr Cameron Reynolds Non-Executive Director Mr Reynolds is the President, Chief Executive Officer (CEO) and Director of VolitionRX, a biotech company which listed on the New York Stock Exchange (NYSE) in February 2015 after being founded by Mr Reynolds in 2010. He has experience in the management, structuring, and strategic planning of start-up companies and has held positions including CEO, Chief Financial Officer and Non-Executive Director of public and private enterprises.
Mr Antonio (Tony) Della Vergiliana Varano	Non-Executive Director,Non-Executive Chairman	May 2018	Mr Antonio (Tony) Della Vergiliana Varano Non-Executive Director,Non-Executive Chairman Mr Varano has more than 30 years experience across Australia, Europe and the USA, operating and managing successful entrepreneurial, corporate and investment pursuits. This experience has covered start up, funding and growth, corporate operations, executive management and business exits. His expertise spans retail, cosmetics, skincare, real estate, agriculture, publishing, construction, entertainment and the arts. New York-based, Mr Varano holds Board and investment positions in several companies he has either founded or invested in at an early stage. Mr Varano studied business at the Western Australian Institute of Technology.
Mr Steven Lorn Schapera	Non-Executive Director	Aug 2017	Mr Steven Lorn Schapera Non-Executive Director Mr Schapera founded the BECCA Cosmetic brand (www.beccacosmetics.com) and commercialised it into a range of cosmetic products that were distributed throughout Europe, Asia and North America. Mr Schapera guided BECCA from its infancy through to being a global player in the luxury cosmetic space. In 2016, BECCA was sold to Estee Lauder for more than US$230 million. Mr Schapera is Chairman of BECCA Holdings Pty. Ltd.; he serves as a non-executive Director on the Board of Invincible Brands GmbH., arguably Europe's most successful influencermarketing business, and recently assisted with their partial sale to Henkel. He is also Founder and Managing Director of London-based Lab Brands Limited and is a non-executive Director of Wild Nutrition Ltd, a fast-growing player in the vitamin and mineral supplement space.
Mr John Joseph Palermo	Company Secretary	May 2008
Mr Jeffrey David Edwards	Managing Director	Oct 2004	Mr Jeffrey David Edwards Managing Director Mr Edwards is responsible for Licensing and Partnering programs with Procter & Gamble and other partners, Intellectual Property and Technology Innovations. He is the recipient of an Australia Design award, and Product Innovation and Partnering awards from Procter & Gamble Consumer Products Divisions.

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
05/05/21	Steven Schapera	Buy	+130,000	$0.06	$7,800	On-market trade
05/05/21	Anthony Wright	Buy	+833,333	$0.06	$49,981	On-market trade
04/05/21	Steven Schapera	Buy	+730,000	$0.058	$42,010	On-market trade
09/04/21	Jeffrey Edwards	Issued	1,347,701	$0.001	$1,347	Issue of options
09/04/21	Cameron Reynolds	Issued	133,333	$0.07	$9,333	Placement
09/04/21	Cameron Reynolds	Issued	266,666	$0.075	$20,000	Placement
09/04/21	Antonio (Tony) Varano	Issued	477,778	$0.07	$33,444	Placement
09/04/21	Antonio (Tony) Varano	Issued	600,000	$0.075	$45,177	Placement
22/12/20	Steven Schapera	Buy	+180,291	$0.14	$25,240	On-market trade
22/09/20	Antonio (Tony) Varano	Transfer	1,125,000	$0.10	$112,500	Off-market transfer
22/09/20	Steven Schapera	Transfer	1,125,000	$0.10	$112,500	Off-market transfer
19/08/20	Antonio (Tony) Varano	Transfer	1,402,330	$0.015	$21,034	Off-market transfer
19/08/20	Antonio (Tony) Varano	Transfer	1,402,330	$0.015	$21,034	Off-market transfer
19/08/20	Antonio (Tony) Varano	Issued	66,667	$0.10	$6,666	Rights issue
19/08/20	Antonio (Tony) Varano	Issued	1,402,330	$0.10	$140,233	Director remuneration
19/08/20	Steven Schapera	Issued	2,250,000	$0.10	$225,000	Placement
19/08/20	Steven Schapera	Issued	1,733,013	$0.10	$173,301	Director remuneration
19/08/20	Cameron Reynolds	Issued	562,500	$0.10	$56,250	Director remuneration
30/04/20	Christopher Quirk	Transfer	1,158,831	$0.015	$17,382	Off-market transfer
30/04/20	Christopher Quirk	Transfer	1,158,831	$0.015	$17,382	Off-market transfer

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Anthony Wright	05/05/2021	0	833,333	N/A	N/A
Steven Schapera	05/05/2021	N/A	4,359,504	N/A	N/A
Cameron Reynolds	09/04/2021	0	829,166	133,333	N/A
Antonio (Tony) Varano	09/04/2021	1,402,330	3,393,997	477,778	N/A
Jeffrey Edwards	09/04/2021	N/A	2,021,550	1,347,701	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
Via Pastura Limited	6,720,000	4.59%
Mr Danny Pavlovich <Pavlovich Family A/C>	3,825,000	2.61%
Sunset Capital Management Pty Ltd <Sunset Superfund A/C>	3,500,000	2.39%
RFID Systems Pty Ltd <The Rfid Consulting A/C>	2,950,000	2.01%
The Brand Laboratories Fz Llc	2,858,013	1.95%
Citicorp Nominees Pty Ltd	2,533,738	1.73%
Rokamaho Pty Ltd <Pumba Blossom A/C>	1,903,334	1.30%
Virtus Capital Pty Ltd	1,846,559	1.26%
Antonio Varano Della Vergiliana	1,402,330	0.96%
Jeb Holdings Pty Ltd <Edwards Family A/C>	1,371,886	0.94%
Jomima Pty Ltd <Internal Equity A/C>	1,207,180	0.82%
Dr Alok Jhamb	1,160,000	0.79%
Sabina Pty Ltd <Australian Enterprise A/C>	1,125,000	0.77%
J P Morgan Nominees Australia Pty Ltd	1,074,945	0.73%
Mr Peter Fedele	981,657	0.67%
HSBC Custody Nominees (Australia) Ltd	910,708	0.62%
Daughters & Co Pty Ltd <Daughters & Co A/C>	881,608	0.60%
Mr Jason Michael Harkess	820,000	0.56%
Mulloway Pty Ltd <John Hartley Poynton Fam A/C>	750,000	0.51%
Provendore Pty Ltd <The Wilks Super Fund A/C>	740,000	0.51%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
No Financial Year End data available

WFL Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.